Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research ...

The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...

Cheetah Mobile posted a quarterly loss of 11 cents per share, versus a year-ago loss of 32 cents per share. The company's ...

The Exosome Research Market presents strong growth opportunities fueled by rising demand for non-invasive diagnostics, ...